The optimal regulatory strategy to promote research and development aimed at cost reduction is derived in an environment where the firm's information about the technology of cost reduction, although initially imperfect, is better than that of the regulator.The manner in which the optimal regulatory strategy varies with changes in the informational environment is also described.
No takes yet. Share an insight, caveat, or question.
David E. M. Sappington (1982) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: